Community/Retail

The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.

Latest News

Eye scan showing macular degeneration -- Image credit: Rabizo Anatolii | stock.adobe.com
Efficacy, Safety, and Immunogenicity Maintained When Patients With nAMD Switch from Eylea to Biosimilar

September 5th 2025

Pavblu, a biosimilar to Eylea, also showed no clinically meaningful differences in efficacy, safety, and immunogenicity in patients with neovascular age-related macular degeneration (nAMD).

Connecticut Pharmacists Association Marks 150 Years of Advocacy, Innovation, and Service
Connecticut Pharmacists Association Marks 150 Years of Advocacy, Innovation, and Service

September 5th 2025

FDA approves risperidone extended-release suspension for schizophrenia -- Image credit: wladimir1804 | stock.adobe.com
Amneal’s Injectable Extended-Release Suspension of Risperidone Receives FDA Approval to Treat Schizophrenia

September 4th 2025

White pills in orange bottle with blood glucose meter on blue background with copy space - Image credit: neirfy | stock.adobe.com
Study Finds Greater Risk of Death From Type 2 Diabetes in Patients With Learning Disabilities

September 4th 2025

Small drug vial with influenza vaccine | Image Credit: Leigh Prather | stock.adobe.com
High-Dose Influenza Vaccine Linked to Lower Risk of Myocarditis, Pericarditis in Older Adults

September 4th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.